Ulceronecrotic penicillosis.

Indian J Dermatol

Department of Dermatology, Venereology and Leprology, Regional Institute of Medical Science, Imphal, Manipur, India.

Published: March 2015

A 40-year-old male human immunodeficiency virus (HIV) -positive patient on highly active antiretroviral therapy (HAART) developed bilateral cervical lymphadenopathy with fine needle aspiration cytology (FNAC) showing yeast cells of Penicillium marneffei. The adenopathy disappeared after 9 months of itraconazole therapy at a dose of 200 mg/day. Seven years later and 2 days following second-line HAART, the patient presented with generalized papulonodules and ulceronecrotic lesions. Biopsy of the skin lesion revealed plenty of yeast forms dividing by binary fission morphologically resembling Penicillium marneffei. Significant improvement was observed at 2 weeks of starting itraconazole 400 mg/day. After 3 months, the dose was reduced to 200 mg/day and advised to continue for 6 months. Penicillosis presenting initially in the form of cervical adenopathy and later, developing typical skin lesions rapidly progressing to ulcerative and necrotic erosions may be due to continued immunosuppression followed by immune reconstitution inflammatory syndrome (IRIS).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372955PMC
http://dx.doi.org/10.4103/0019-5154.152607DOI Listing

Publication Analysis

Top Keywords

penicillium marneffei
8
200 mg/day
8
ulceronecrotic penicillosis
4
penicillosis 40-year-old
4
40-year-old male
4
male human
4
human immunodeficiency
4
immunodeficiency virus
4
virus hiv
4
hiv -positive
4

Similar Publications

Background: In acquired immunodeficiency syndrome patients, Talaromyces marneffei infections are mostly disseminated and may involve the skin, mucosa, respiratory system, digestive system, lymphatic system, and as some reports indicate, the nervous system. Mp1p, a cell wall-specific polysaccharide in Talaromyces marneffei, is used for laboratory diagnosis of Talaromyces marneffei in blood and urine samples. However, Cerebrospinal fluid Mp1p diagnosis of Talaromyces marneffei central nervous system infection has not been reported.

View Article and Find Full Text PDF

Aims: The present study aims to investigate the in vitro antifungal activity and mechanism of action of bamemacrolactine C (BAC), a new 24-membered macrolide compound, against Talaromyces marneffei.

Methods And Results: The test drug BAC initially demonstrated antifungal activity through a paper disk diffusion assay, followed by determination of the minimum inhibitory concentration value of 35.29 μg ml-1 using microdilution.

View Article and Find Full Text PDF

Objectives: This systematic review and meta-analysis aimed to evaluate the prevalence of bone destruction in patients with Talaromyces marneffei infection, examine distribution patterns of bone lesions, and assess differences between HIV-positive and HIV-negative patients.

Methods: Following PRISMA guidelines, 15 studies involving 839 patients were analyzed. Random-effects meta-analysis was performed to estimate prevalence and odds ratios.

View Article and Find Full Text PDF
Article Synopsis
  • - High levels of antibodies to interferon-gamma (IFN-γ) are linked to infections from intracellular pathogens, especially non-tuberculous mycobacteria (NTM) and tuberculosis (MTB).
  • - The case study discusses a non-immunosuppressed patient who had both MTB infection and complications from NTM, which led to a severe condition called secondary hemophagocytic syndrome.
  • - The report emphasizes the importance of recognizing this uncommon combination of infections to prevent misdiagnosis or unnecessary treatments for patients.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!